 Alia Al-Tayyib
Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance Abuse, Intravenous | 9 | 2020 | 115 | 2.490 |
Why?
| | Opioid-Related Disorders | 8 | 2025 | 515 | 2.010 |
Why?
| | Homosexuality, Male | 8 | 2022 | 184 | 1.580 |
Why?
| | Methadone | 2 | 2025 | 101 | 1.190 |
Why?
| | Hepatitis C | 7 | 2025 | 271 | 1.180 |
Why?
| | Opiate Substitution Treatment | 3 | 2025 | 155 | 1.120 |
Why?
| | Analgesics, Opioid | 6 | 2025 | 1000 | 1.070 |
Why?
| | HIV Infections | 20 | 2025 | 2836 | 1.010 |
Why?
| | Prescription Drug Misuse | 2 | 2017 | 41 | 0.950 |
Why?
| | Gonorrhea | 4 | 2012 | 59 | 0.920 |
Why?
| | Sexual Behavior | 10 | 2022 | 485 | 0.900 |
Why?
| | Heroin Dependence | 2 | 2017 | 33 | 0.860 |
Why?
| | Emergency Service, Hospital | 13 | 2025 | 2069 | 0.800 |
Why?
| | Amphetamine-Related Disorders | 3 | 2024 | 40 | 0.790 |
Why?
| | Chlamydia Infections | 5 | 2012 | 75 | 0.770 |
Why?
| | Methamphetamine | 4 | 2024 | 63 | 0.700 |
Why?
| | Unsafe Sex | 4 | 2017 | 60 | 0.670 |
Why?
| | Sexual Partners | 6 | 2018 | 186 | 0.650 |
Why?
| | Mass Screening | 11 | 2025 | 1287 | 0.640 |
Why?
| | Drug Overdose | 4 | 2025 | 347 | 0.630 |
Why?
| | Internet | 2 | 2017 | 655 | 0.590 |
Why?
| | Substance-Related Disorders | 6 | 2025 | 1083 | 0.580 |
Why?
| | Buprenorphine | 1 | 2021 | 173 | 0.570 |
Why?
| | Colorado | 13 | 2025 | 4565 | 0.550 |
Why?
| | Hepacivirus | 5 | 2025 | 261 | 0.510 |
Why?
| | Prescription Drugs | 1 | 2016 | 109 | 0.460 |
Why?
| | Adult | 38 | 2025 | 37929 | 0.460 |
Why?
| | Mobile Applications | 1 | 2017 | 183 | 0.430 |
Why?
| | Homeless Youth | 1 | 2013 | 17 | 0.420 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 273 | 0.400 |
Why?
| | Male | 43 | 2025 | 67762 | 0.390 |
Why?
| | Primary Prevention | 1 | 2014 | 196 | 0.380 |
Why?
| | Risk-Taking | 8 | 2020 | 348 | 0.360 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2020 | 1329 | 0.360 |
Why?
| | Public Health | 1 | 2016 | 588 | 0.350 |
Why?
| | Middle Aged | 23 | 2025 | 33479 | 0.330 |
Why?
| | Social Stigma | 2 | 2022 | 137 | 0.330 |
Why?
| | Comorbidity | 3 | 2021 | 1622 | 0.310 |
Why?
| | Humans | 50 | 2025 | 137585 | 0.310 |
Why?
| | Female | 36 | 2025 | 73304 | 0.300 |
Why?
| | Young Adult | 16 | 2024 | 13209 | 0.300 |
Why?
| | Heterosexuality | 3 | 2018 | 43 | 0.300 |
Why?
| | Attitude | 1 | 2011 | 259 | 0.300 |
Why?
| | Telephone | 2 | 2009 | 173 | 0.300 |
Why?
| | Safety-net Providers | 2 | 2020 | 119 | 0.290 |
Why?
| | Heroin | 2 | 2020 | 31 | 0.290 |
Why?
| | Prevalence | 6 | 2019 | 2734 | 0.290 |
Why?
| | Adolescent | 20 | 2021 | 21513 | 0.280 |
Why?
| | Surveys and Questionnaires | 4 | 2017 | 5778 | 0.280 |
Why?
| | Health Services Accessibility | 3 | 2022 | 986 | 0.270 |
Why?
| | Self Disclosure | 2 | 2009 | 63 | 0.260 |
Why?
| | Cost-Benefit Analysis | 3 | 2025 | 591 | 0.250 |
Why?
| | United States | 18 | 2025 | 14841 | 0.240 |
Why?
| | Cities | 4 | 2020 | 133 | 0.240 |
Why?
| | Interviews as Topic | 4 | 2024 | 786 | 0.240 |
Why?
| | Models, Economic | 1 | 2025 | 58 | 0.230 |
Why?
| | Psychoses, Substance-Induced | 1 | 2024 | 13 | 0.220 |
Why?
| | Housing | 1 | 2025 | 146 | 0.220 |
Why?
| | Chlamydia trachomatis | 3 | 2008 | 49 | 0.220 |
Why?
| | Behavioral Risk Factor Surveillance System | 4 | 2017 | 53 | 0.210 |
Why?
| | Socioeconomic Factors | 6 | 2020 | 1289 | 0.200 |
Why?
| | Baltimore | 3 | 2008 | 60 | 0.190 |
Why?
| | Health Surveys | 2 | 2009 | 514 | 0.180 |
Why?
| | Insurance, Health | 2 | 2015 | 283 | 0.180 |
Why?
| | Family Planning Services | 1 | 2022 | 92 | 0.180 |
Why?
| | Consensus | 1 | 2024 | 683 | 0.170 |
Why?
| | Sexual and Gender Minorities | 2 | 2022 | 214 | 0.170 |
Why?
| | Needle Sharing | 1 | 2020 | 10 | 0.170 |
Why?
| | Needle-Exchange Programs | 1 | 2020 | 9 | 0.170 |
Why?
| | Patient-Centered Care | 1 | 2025 | 530 | 0.160 |
Why?
| | Risk | 2 | 2016 | 912 | 0.160 |
Why?
| | Educational Status | 1 | 2002 | 470 | 0.160 |
Why?
| | Drug Users | 1 | 2020 | 40 | 0.160 |
Why?
| | Allied Health Personnel | 1 | 2020 | 46 | 0.160 |
Why?
| | Washington | 2 | 2020 | 156 | 0.150 |
Why?
| | Neisseria gonorrhoeae | 2 | 2008 | 26 | 0.150 |
Why?
| | HIV | 3 | 2019 | 234 | 0.140 |
Why?
| | Cohort Studies | 3 | 2025 | 5742 | 0.140 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2020 | 213 | 0.140 |
Why?
| | Qualitative Research | 1 | 2024 | 1386 | 0.130 |
Why?
| | Condoms | 2 | 2014 | 103 | 0.120 |
Why?
| | Patient Acceptance of Health Care | 2 | 2012 | 806 | 0.120 |
Why?
| | Patient Participation | 1 | 2019 | 420 | 0.120 |
Why?
| | Emergency Medical Services | 2 | 2020 | 552 | 0.120 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 103 | 0.110 |
Why?
| | Interpersonal Relations | 1 | 2018 | 397 | 0.110 |
Why?
| | Public Health Surveillance | 1 | 2015 | 82 | 0.110 |
Why?
| | Reproductive Health | 1 | 2015 | 90 | 0.110 |
Why?
| | Health Care Reform | 1 | 2015 | 107 | 0.110 |
Why?
| | Adolescent Behavior | 1 | 2020 | 530 | 0.110 |
Why?
| | Machine Learning | 1 | 2020 | 493 | 0.110 |
Why?
| | Insurance Coverage | 2 | 2015 | 230 | 0.110 |
Why?
| | Sexually Transmitted Diseases | 1 | 2015 | 161 | 0.110 |
Why?
| | Contact Tracing | 1 | 2012 | 27 | 0.100 |
Why?
| | Prospective Studies | 6 | 2025 | 7604 | 0.100 |
Why?
| | AIDS Serodiagnosis | 1 | 2012 | 24 | 0.090 |
Why?
| | Hepatitis C Antibodies | 1 | 2011 | 11 | 0.090 |
Why?
| | Sex Factors | 1 | 2017 | 2071 | 0.090 |
Why?
| | Risk Assessment | 2 | 2025 | 3457 | 0.090 |
Why?
| | Clinical Laboratory Techniques | 1 | 2011 | 97 | 0.090 |
Why?
| | Health Promotion | 1 | 2017 | 741 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1509 | 0.080 |
Why?
| | Cross-Sectional Studies | 3 | 2011 | 5472 | 0.080 |
Why?
| | ROC Curve | 1 | 2011 | 554 | 0.080 |
Why?
| | Urban Population | 2 | 2012 | 479 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2013 | 421 | 0.070 |
Why?
| | Treatment Outcome | 3 | 2023 | 10811 | 0.070 |
Why?
| | Tape Recording | 1 | 2005 | 13 | 0.060 |
Why?
| | Life Expectancy | 1 | 2025 | 69 | 0.060 |
Why?
| | Alcoholism | 2 | 2020 | 807 | 0.060 |
Why?
| | Bias | 1 | 2005 | 218 | 0.050 |
Why?
| | Age Factors | 2 | 2009 | 3295 | 0.050 |
Why?
| | Risk Factors | 3 | 2019 | 10388 | 0.050 |
Why?
| | Logistic Models | 1 | 2008 | 2074 | 0.050 |
Why?
| | Central Nervous System Stimulants | 1 | 2024 | 161 | 0.050 |
Why?
| | Data Collection | 1 | 2005 | 673 | 0.050 |
Why?
| | Sex Education | 1 | 2022 | 30 | 0.050 |
Why?
| | Pregnancy, Unplanned | 1 | 2022 | 48 | 0.050 |
Why?
| | RNA, Viral | 1 | 2025 | 656 | 0.050 |
Why?
| | Intention to Treat Analysis | 1 | 2021 | 73 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2008 | 3556 | 0.040 |
Why?
| | Contraception | 1 | 2022 | 161 | 0.040 |
Why?
| | Oregon | 1 | 2020 | 74 | 0.040 |
Why?
| | Genotype | 1 | 2025 | 1916 | 0.040 |
Why?
| | Algorithms | 1 | 2008 | 1704 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 213 | 0.040 |
Why?
| | Aged | 2 | 2016 | 23961 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2020 | 245 | 0.040 |
Why?
| | Odds Ratio | 1 | 2021 | 1070 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2024 | 786 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 500 | 0.040 |
Why?
| | Gender Identity | 1 | 2018 | 124 | 0.030 |
Why?
| | Family | 1 | 2022 | 671 | 0.030 |
Why?
| | Self Efficacy | 1 | 2020 | 396 | 0.030 |
Why?
| | Medicaid | 1 | 2020 | 435 | 0.030 |
Why?
| | Minority Groups | 1 | 2018 | 266 | 0.030 |
Why?
| | Censuses | 1 | 2015 | 31 | 0.030 |
Why?
| | Health Status | 1 | 2020 | 792 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 951 | 0.030 |
Why?
| | Cognition | 1 | 2002 | 1153 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 1069 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2019 | 744 | 0.030 |
Why?
| | Phylogeny | 1 | 2017 | 904 | 0.030 |
Why?
| | Research Design | 1 | 2019 | 1139 | 0.020 |
Why?
| | Medical Assistance | 1 | 2012 | 12 | 0.020 |
Why?
| | Hospitals, Urban | 1 | 2012 | 134 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2008 | 15657 | 0.020 |
Why?
| | Guidelines as Topic | 1 | 2012 | 275 | 0.020 |
Why?
| | Hospitalization | 1 | 2020 | 2199 | 0.020 |
Why?
| | Comprehension | 1 | 2012 | 172 | 0.020 |
Why?
| | Saliva | 1 | 2011 | 242 | 0.020 |
Why?
| | Triage | 1 | 2012 | 222 | 0.020 |
Why?
| | Child | 2 | 2020 | 21935 | 0.020 |
Why?
| | Hepatitis C, Chronic | 1 | 2011 | 164 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 6763 | 0.020 |
Why?
| | Computers | 1 | 2009 | 70 | 0.020 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2009 | 64 | 0.020 |
Why?
| | Contraception Behavior | 1 | 2009 | 102 | 0.020 |
Why?
| | User-Computer Interface | 1 | 2009 | 159 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 482 | 0.020 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2007 | 37 | 0.020 |
Why?
| | Urban Health | 1 | 2007 | 92 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2012 | 1050 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1946 | 0.020 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2005 | 89 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3284 | 0.010 |
Why?
|
|
Al-Tayyib's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|